Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
4.730
-0.030 (-0.63%)
Jun 27, 2025, 11:22 AM - Market open
AVTX's stock price has decreased by -63.19% in the past year and price targets may not have had time to catch up.

Avalo Therapeutics Analyst Ratings

Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$31.00
Upside
+555.39%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$15
Strong Buy Initiates $15 +217.12% Jun 2, 2025
Jefferies
Jefferies
Strong Buy
Initiates
$23
Strong Buy Initiates $23 +386.26% Mar 25, 2025
Stifel
Stifel
Strong Buy
Initiates
$36
Strong Buy Initiates $36 +661.10% Mar 25, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Mar 20, 2025
Piper Sandler
Piper Sandler
Buy
Initiates
$48
Buy Initiates $48 +914.80% Feb 28, 2025
BTIG
BTIG
Strong Buy
Initiates
$40
Strong Buy Initiates $40 +745.67% Dec 19, 2024
LUCID CAPITAL MARKETS
LUCID CAPITAL MARKETS
Strong Buy
Initiates
$24
Strong Buy Initiates $24 +407.40% Dec 17, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Initiates
n/a
Hold Initiates n/a n/a Oct 24, 2024
Oppenheimer
Oppenheimer
Buy
Upgrades
$35
Buy Upgrades $35 +639.96% Apr 16, 2024
Oppenheimer
Oppenheimer
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Jun 27, 2023
RBC Capital
RBC Capital
Hold
Downgrades
$2,160$180
Hold Downgrades $2,160$180 +3,705.50% Jun 27, 2023
RBC Capital
RBC Capital
Buy
Maintains
$4,080$2,160
Buy Maintains $4,080$2,160 +45,565.96% May 10, 2023
Jefferies
Jefferies
Sell
Downgrades
$720
Sell Downgrades $720 +15,121.99% Feb 8, 2023
Jefferies
Jefferies
Hold
Downgrades
$14,400$2,160
Hold Downgrades $14,400$2,160 +45,565.96% Mar 3, 2022
RBC Capital
RBC Capital
Buy
Maintains
$14,400$11,520
Buy Maintains $14,400$11,520 +243,451.80% Mar 3, 2022
RBC Capital
RBC Capital
Buy
Initiates
$17,280
Buy Initiates $17,280 +365,227.70% Sep 24, 2021